Aerolase Era Elite
Er:YAG Resurfacing · 300-microsecond Er:YAG 2940nm
The Aerolase Era Elite typically sells new in the $60k–$90k range in the US. Aerolase Era Elite's FDA status is under verification by our research team. Figures are market estimates verified August 9, 2026.
What it's actually cleared for: 2940nm Er:YAG resurfacing; manufacturer states cleared (LightPod Era family) — K not located, verify
Last verified: August 9, 2026 · How we verify
New: $60k–$90k|Used: —market estimate, no email required
| Manufacturer | Aerolase |
|---|---|
| Company | Ownership: not yet verified. |
| Category | Resurfacing, Tattoo & Vascular |
| Technology | 300-microsecond Er:YAG 2940nm |
| FDA status | Cleared — citation pending verification |
| New price range | $60k–$90k |
| Used price range | Not published |
| Consumables | Not published |
| Launch year | 2021 |
| Last verified | August 9, 2026 |
Bottom line
Aerolase's 2940nm erbium resurfacing companion to the Neo — "cold ablation" full-field erbium giving resurfacing revenue without the CO2 downtime conversation or a fractional-tip consumable bill. Results on texture, sun damage, and perioral lines are real, but it's still ablative: several days of social downtime at meaningful settings, and it lacks CO2's deep coagulation for heavy laxity. Most buyers acquire it bundled with a Neo — that pairing is where the economics sing.
Overview
Pain-tolerant micropulse erbium resurfacing
How it works
The science
2940nm Er:YAG — the wavelength most strongly absorbed by water — delivered in Aerolase's short 300-microsecond-class pulses, ablating micron-thin layers with minimal residual thermal damage ("cold" ablation), shortening healing versus CO2 at comparable superficial depths. Titrates from light epidermal glow peels to deeper full-field resurfacing for rhytides, photodamage, texture, scars. Full-field rather than fractional: downtime tracks depth — light peels 2-4 days, deeper work 5-10.
Patented tech
The same 650 Microsecond platform philosophy applied to erbium — compact air-cooled head firing short-duration 2940nm pulses; ablation with less lingering heat, not a novel delivery system.
Origin
USA (Tarrytown, New York).
FDA & regulatory status
Clearance is expected for this platform, but we have not yet confirmed the exact authorization number against the public FDA database, so no number is published here. See our FDA guide.
What it's actually cleared for:
2940nm Er:YAG resurfacing; manufacturer states cleared (LightPod Era family) — K not located, verify
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
What practices charge
~$400-800 light full-face erbium glow sessions; $1,200-2,500 deeper full-face resurfacing, one to three treatments. Perioral/periorbital segments $350-700. Add-on pricing to Neo packages is common.
Consumables & recurring cost
None per treatment — no fractional tips, no gas, no gel; negligible annual cost, the direct economic argument against tip-based resurfacing platforms.
Ideal for
Best-fit practice
Practices that already own a Neo wanting an ablative upsell path; derm/plastics offices wanting erbium resurfacing with simple logistics. Patients skew Fitzpatrick I-III photodamage and perioral lines 45+. Not the tool for predominantly darker-skin bases seeking deep resurfacing.
Compliance
Medical director & delegation
Ablative Class IV laser — physician/mid-level territory in most states with far less delegation latitude than non-ablative devices.
Contraindications & screening
Isotretinoin history, keloid tendency, active HSV (antiviral prophylaxis required), immunosuppression, darker phototypes for deep work, poor wound-care compliance.
Ownership
Warranty & service
Typically 2 years with Aerolase's US service organization; simple architecture keeps repair exposure lower than flashlamp CO2 systems.
Resale & used market
Thinner and slower than the Neo — Era units surface at ~$20k-40k and sit longer; moderate, flat liquidity.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 9, 2026
FDA status
Cleared → Cleared-Pending-Citation
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.